This study aims to investigate, by means of in vitro and in vivo studies, the effects of MOR activation and blockage on HNSCC, with relation to disease progression, response to therapy, and activation of the PI3K/AKT/mTOR signaling axis. Here, OPRM1 is linked to head and neck squamous cell carcinoma.